Xiaowei Dong Department of Pharmaceutical Sciences, College of Pharmacy University of North Texas Health Science Center Biography Publications Institution JoVE Articles Xiaowei Dong has not added a biography. If you are Xiaowei Dong and would like to personalize this page please email our Author Liaison for assistance. Publications Development of Novel HDL-mimicking α-tocopherol-coated Nanoparticles to Encapsulate Nerve Growth Factor and Evaluation of Biodistribution European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. Nov, 2016 | Pubmed ID: 27531623 Novel in Situ Self-assembly Nanoparticles for Formulating a Poorly Water-soluble Drug in Oral Solid Granules, Improving Stability, Palatability, and Bioavailability International Journal of Nanomedicine. 2016 | Pubmed ID: 27103803 Impaired Dendritic Development and Memory in Sorbs2 Knock-Out Mice The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Feb, 2016 | Pubmed ID: 26888934 Development and in Vivo Evaluation of Child-friendly Lopinavir/ritonavir Pediatric Granules Utilizing Novel in Situ Self-assembly Nanoparticles Journal of Controlled Release : Official Journal of the Controlled Release Society. Mar, 2016 | Pubmed ID: 26849919 Decreased Platelet 5-hydroxytryptamin (5-HT) Levels: a Response to Antidepressants Journal of Affective Disorders. Nov, 2015 | Pubmed ID: 26321259 Solubilization of Tea Seed Oil in a Food-grade Water-dilutable Microemulsion PloS One. 2015 | Pubmed ID: 25996147 Prevalence and Related Factors of Irritable Bowel Syndrome Among Middle-school Students in Areas Affected by Wenchuan Earthquake: an Epidemiological Study Journal of Clinical Gastroenterology. Apr, 2012 | Pubmed ID: 22395064 Precise Method for Modifying Birefringence of Stress-induced High-birefringence Fiber Optics Letters. Sep, 2010 | Pubmed ID: 20808385 Nanomedicinal Strategies to Treat Multidrug-resistant Tumors: Current Progress Nanomedicine (London, England). Jun, 2010 | Pubmed ID: 20528455 P21 Waf1/Cip1 Polymorphisms and Risk of Esophageal Cancer Annals of Surgical Oncology. May, 2010 | Pubmed ID: 20112071 Development of Idarubicin and Doxorubicin Solid Lipid Nanoparticles to Overcome Pgp-mediated Multiple Drug Resistance in Leukemia Journal of Biomedical Nanotechnology. Apr, 2009 | Pubmed ID: 20055093 Doxorubicin and Paclitaxel-loaded Lipid-based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-glycoprotein and Depleting ATP Cancer Research. May, 2009 | Pubmed ID: 19383919 Development of New Lipid-based Paclitaxel Nanoparticles Using Sequential Simplex Optimization European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. May, 2009 | Pubmed ID: 19111929 Preparação e caracterização de novas nanopartículas simuladoras de HDL para encapsulação de fatores de crescimento nervoso Jing Zhu1, Xiaowei Dong1 1Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center JoVE 55584 Bioengineering
Preparação e caracterização de novas nanopartículas simuladoras de HDL para encapsulação de fatores de crescimento nervoso Jing Zhu1, Xiaowei Dong1 1Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center JoVE 55584 Bioengineering